Αποτελέσματα Αναζήτησης
Two Special Issues are coming in 2025: New Anticancer Agents – 2025 (Submission deadline: May 10, 2025; Publication date: July 2025). Click here for more information. Advances in Renal Cell Carcinoma Diagnosis and Treatment – 2025 (Submission deadline: July 10, 2025; Publication date: October 2025). Click here for more information.
- Current Issue
Comparison of the Predictive and Prognostic Capacities of...
- Archive
Potential Transcriptomic Biomarkers for Predicting...
- Other Publications
I grant the International Institute of Anticancer Research...
- About Us
ANTICANCER RESEARCH is an independent international...
- Subscribers
For assistance with your print subscription, please contact...
- Advertisers
The exceptional success of ANTICANCER RESEARCH is attributed...
- Editorial Board
P.A. Abrahamsson. Department of Urology, Skåne University...
- In Vivo
Three Special Issues are coming in 2025: Circulating Tumor...
- Current Issue
Anticancer Research is an international journal designed to rapidly publish original papers and reviews on experimental and clinical cancer research. Anticancer Research was established in 1981 by J.G. Delinasios.
Search for specific authors and/or words and phrases.
Three Special Issues are coming in 2025: Circulating Tumor Cells: Cellular and Molecular Biology; Applications in Cancer Diagnosis and Prognosis – 2025 (Submission deadline: May 30, 2025; Publication date: September 2025). Click here for more information.
Comparison of the Predictive and Prognostic Capacities of Neutrophil, Lymphocyte and Platelet Counts and Tumor-infiltrating Lymphocytes in Triple-negative Breast Cancer: Preliminary Results of the PERCEPTION Study ($30)
Anticancer Research publishes original articles and reviews on experimental and clinical aspects of cancer research. It is indexed by Scopus and has an H-index of 136 and a SJR of 0.8.
Anticancer Research is a monthly peer-reviewed journal on oncology, published by the International Institute of Anticancer Research. It covers experimental and clinical topics in cancer research, and has an impact factor of 2.480 and a rejection rate of 68%.
